Glucotrack (GCTK) Debt to Equity (2010 - 2025)

Glucotrack (GCTK) recorded quarterly Debt to Equity of $0.08 in Q3 2025, up 156.88% on a QoQ basis from $0.03 in Q2 2025.

Glucotrack (GCTK) Debt to Equity (2010 - 2025) Analysis & Trends

Glucotrack has disclosed Debt to Equity across 15 years of filings, most recently posting $0.08 for Q3 2025.

Quarterly Debt to Equity changed N/A year-over-year to $0.08 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $0.08 (changed N/A YoY) and the FY2024 annual result came in at -$0.02, changed N/A from the prior year.
Debt to Equity grew to $0.08 in Q3 2025, from $0.03 in the prior quarter.
Over five years, Debt to Equity peaked at $0.16 in Q4 2022 and troughed at -$0.02 in Q4 2024.
A 4-year average of $0.05 and a median of $0.04 in 2021 frame the typical range for Debt to Equity.
Annual changes were most pronounced in 2021 — Debt to Equity surged 39.39% — and 2022, when it soared 289.17%.
Tracing GCTK's Debt to Equity over 4 years: stood at $0.04 in 2021, then surged by 289.17% to $0.16 in 2022, then slumped by 109.85% to -$0.02 in 2024, then jumped by 628.42% to $0.08 in 2025.
Business Quant data shows GCTK's Debt to Equity at $0.08 in Q3 2025, $0.03 in Q2 2025, and $0.03 in Q1 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt/Equity (Qtr)
1	Intuitive Surgical	148.09 Bn	143.69 Bn	1.83 Bn	-
2	Becton Dickinson	41.00 Bn	39.99 Bn	2.15 Bn	0.72
3	Medline	30.38 Bn	36.22 Bn	1.84 Bn	1.12
4	Resmed	28.22 Bn	26.56 Bn	890.98 Mn	0.04
5	West Pharmaceutical Services	23.72 Bn	23.19 Bn	296.40 Mn	0.07
6	Solventum	13.33 Bn	13.33 Bn	1.10 Bn	1.02
7	Cooper Companies	13.12 Bn	12.99 Bn	735.40 Mn	0.30
8	Align Technology	12.86 Bn	11.80 Bn	736.59 Mn	-
9	Baxter International	10.51 Bn	8.47 Bn	891.00 Mn	1.57
10	Glucotrack	4.26	-7.38 Mn	-	-

Download Data